← Back to Search

PARO therapy seal for Critical Illness (PARO Trial)

N/A
Waitlist Available
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week of study completion
Awards & highlights

PARO Trial Summary

This study is evaluating whether a robot can help reduce the amount of sedative and analgesic medication needed by critically ill children.

Eligible Conditions
  • Critical Illness
  • Acute Lymphoblastic Leukemia
  • Physical Therapy
  • Occupational Therapy
  • Animal Assisted Therapy

PARO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~chart review will be conducted from the first day the patient is enrolled until 1 week after study completion.
This trial's timeline: 3 weeks for screening, Varies for treatment, and chart review will be conducted from the first day the patient is enrolled until 1 week after study completion. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Activity performance form
Anxiety: Children's Anxiety Meter-State (CAM-S)
Hospital Acquired Infections
+5 more

PARO Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The PT/OT provider will assess whether the patient meets eligibility criteria. If the patient is eligible to participate, they will then introduce the study to the patient and their parent or guardian. If the patient is interested in participating, the PI or PIs research assistant (RA) will seek written informed consent. After informed consent is obtained, the PI or RA will begin pretest data collection. Then, the PT/OT provider will begin the therapy session with Paro. The PI or RA will remain in the room during therapy session to record field notes. When the therapy session is complete, the PI or RA will begin posttest data collection. The patient will remain in the study for up to 7 PT/OT sessions or until they are discharged from the PICU. The PT/OT providers will coordinate all subsequent therapy sessions with the PI/RA while the patient remains on the study protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PARO therapy seal
2019
N/A
~20

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,715 Total Patients Enrolled
1 Trials studying Critical Illness
8,100 Patients Enrolled for Critical Illness

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Animal Assisted Interactions With Animal Robot During PT/OT in the ICU
Breanna Hetland, PHD, RN, CCRN-K 2019. "Animal Assisted Interactions With Animal Robot During PT/OT in the ICU". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05075395.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top